Our Vision: A New Standard of Trust in Clinical Development
Setting the standard for more transparent and accountable clinical development, driven by our ambition to become Europe’s most trusted partner for biotech, emerging pharma, and innovative healthcare companies.
Our Mission: We Guide You with Clarity & Confidence
We help biotech leaders move through clinical development with clarity and control. From early-phase planning to full clinical execution, we lead with strategy, communicate openly, and anticipate challenges before they arise, helping meaningful therapies reach patients with precision and care.
The Clarenta Story
Our story began in Bulgaria in 1997, when Comac Medical was established as a family-owned clinical research company. From a small team with an entrepreneurial spirit, it grew into one of Central and Eastern Europe’s leading full-service CROs, expanding its expertise across the clinical development journey and building a presence in more than 20 countries.
In May 2025, ILIFE Consulting became part of Comac Medical Group, bringing complementary strengths in strategic consulting, early-phase oncology, rare diseases, and complex biotech trials. Together, the two organizations combined decades of operational experience with specialist scientific insight and a shared belief in close, responsive client partnerships.
On 9 September 2026, this remarkable journey entered a new chapter with the launch of Clarenta. Our new identity reflects our evolution from an operational CRO into an integrated strategic clinical development partner, one that brings together consulting, early-phase capabilities, and full-service clinical execution.
Our expertise is on the ground
Clarenta’s European presence is built around our people. Our teams combine local market knowledge with expertise in clinical operations, regulatory, medical and scientific affairs, feasibility, site management, project management and development consulting.
Our largest team is in Bulgaria, with more than 180 colleagues across our Early Phase Unit, Clinical Operations, Regulatory & Safety, Scientific & Medical Affairs, Quality, Laboratory Services, Site Management and Feasibility.
In France, our growing team strengthens Clarenta’s early development capabilities through development consulting, regulatory, project management, clinical and medical expertise.
Our teams in Germany and the United Kingdom contribute local insight and specialist expertise to development programmes across Europe.
Elsewhere, North Macedonia has a strong Clinical Operations team, supported by regulatory, medical, feasibility and site management expertise. Georgia combines Clinical Monitoring with Regulatory & Safety and Feasibility. Our teams in Poland, Romania and Turkey provide complementary capabilities across Clinical Monitoring, Regulatory & Safety, Scientific & Medical Affairs, Feasibility and Site Management.
Clarenta also has a Business Development presence in the United States, connecting US-based clients with our European teams.
Different places. One team.
Clarenta colleagues are based across Albania, Armenia, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lithuania, Moldova, the Netherlands, North Macedonia, Poland, Romania, Serbia, Slovenia, Spain, Turkey, the United Kingdom and Uzbekistan.
Across these markets, our people include clinical research professionals, CRAs and monitors, regulatory specialists, medical and scientific experts, feasibility and site management professionals, project managers, consultants and business development teams, connected across countries and disciplines as one Clarenta team.
Our internal presence is complemented by an established network of experienced clinical professionals and partners, extending our ability to support studies in additional European markets.
300+ colleagues. Local expertise across Europe. One connected team.
Our Values
CLARITY OVER COMPLEXITY
We cut through the noise to make the path forward clear.
CLARITY OVER COMPLEXITY
Every conversation, recommendation, and deliverable is designed to make the path forward unmistakable, because confident decisions start with clear information.
STRATEGIC PARTNERSHIP
Your success is the measure of ours, at every stage.
STRATEGIC PARTNERSHIP
We don’t wait to be directed. We think alongside you, anticipate what’s coming, and stay genuinely invested in where your programme needs to go.
SCIENTIFIC INTEGRITY
We are grounded in science and guided by conscience.
SCIENTIFIC INTEGRITY
Deep scientific knowledge meets operational experience. Every recommendation is evidence-based and delivered with the moral clarity complex trials demand.
TRANSPARENT BY NATURE
We say the hard things early, clearly and openly.
TRANSPARENT BY NATURE
By communicating openly about risks, timelines, and challenges, we
protect our clients from surprises and build the kind of trust that makes difficult decisions easier.
Our Approach to Partnership
We partner with biotech companies, emerging and mid-sized pharmaceutical organizations, and CROs navigating complex clinical development challenges.
1. Understand the Challenge
We begin by listening, exploring your science, development objectives, operational realities, and stakeholder priorities to understand what success requires.
2. Define the Right Path
Our senior experts translate complexity into a clear, evidence-based strategy tailored to your programme, resources, and stage of development.
3. Build the Right Team
We shape our support around your needs, bringing together the right expertise and working as a responsive extension of your internal team.
4. Navigate Proactively
We anticipate risks, communicate difficult issues early, and adapt quickly as new information emerges, helping you make confident, timely decisions.
5. Deliver with Accountability
We maintain clear visibility of progress, decisions, timelines, and responsibilities. From strategy through execution, we take ownership and remain focused on the outcomes that matter.
